Cefotaxime sodium therapy for endomyometritis following cesarean section: Dose-finding and comparative studies

D. L. Hemsell, F. G. Cunningham, R. T. DePalma, B. J. Nobles, M. Heard, P. G. Hemsell

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

One hundred eighteen women who developed endomyometritis after cesarean section in Parkland Memorial Hospital were treated with parenteral cefotaxime sodium. The requirement for additional antimicrobial therapy was significantly higher at an initial daily dose of 3 g/day (16.4%) than when the dose was 6 g/day (4.8%) (P < .05). The latter clinical efficacy and the observed in vitro susceptibility of 88% of isolates indicate that cefotaxime is well suited for single-agent parenteral therapy for this polymicrobial pelvic infection. Subsequently, 120 women with the same diagnosis were randomly treated with cefotaxime or clindamycin and gentamicin. Patient populations, surgical variables, in vitro microbiologic data, and side effects were similar for both groups. Clinical success observed was also similar: it was 97.5% for women given cefotaxime and 95% for women given clindamycin and gentamicin.

Original languageEnglish (US)
Pages (from-to)489-497
Number of pages9
JournalObstetrics and Gynecology
Volume62
Issue number4
StatePublished - 1983

Fingerprint

Endometritis
Cefotaxime
Cesarean Section
Clindamycin
Gentamicins
Pelvic Infection
Therapeutics
Coinfection
Population
In Vitro Techniques

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Cefotaxime sodium therapy for endomyometritis following cesarean section : Dose-finding and comparative studies. / Hemsell, D. L.; Cunningham, F. G.; DePalma, R. T.; Nobles, B. J.; Heard, M.; Hemsell, P. G.

In: Obstetrics and Gynecology, Vol. 62, No. 4, 1983, p. 489-497.

Research output: Contribution to journalArticle

@article{7b18f74d853745d3a5170eb3a920f4da,
title = "Cefotaxime sodium therapy for endomyometritis following cesarean section: Dose-finding and comparative studies",
abstract = "One hundred eighteen women who developed endomyometritis after cesarean section in Parkland Memorial Hospital were treated with parenteral cefotaxime sodium. The requirement for additional antimicrobial therapy was significantly higher at an initial daily dose of 3 g/day (16.4{\%}) than when the dose was 6 g/day (4.8{\%}) (P < .05). The latter clinical efficacy and the observed in vitro susceptibility of 88{\%} of isolates indicate that cefotaxime is well suited for single-agent parenteral therapy for this polymicrobial pelvic infection. Subsequently, 120 women with the same diagnosis were randomly treated with cefotaxime or clindamycin and gentamicin. Patient populations, surgical variables, in vitro microbiologic data, and side effects were similar for both groups. Clinical success observed was also similar: it was 97.5{\%} for women given cefotaxime and 95{\%} for women given clindamycin and gentamicin.",
author = "Hemsell, {D. L.} and Cunningham, {F. G.} and DePalma, {R. T.} and Nobles, {B. J.} and M. Heard and Hemsell, {P. G.}",
year = "1983",
language = "English (US)",
volume = "62",
pages = "489--497",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Cefotaxime sodium therapy for endomyometritis following cesarean section

T2 - Dose-finding and comparative studies

AU - Hemsell, D. L.

AU - Cunningham, F. G.

AU - DePalma, R. T.

AU - Nobles, B. J.

AU - Heard, M.

AU - Hemsell, P. G.

PY - 1983

Y1 - 1983

N2 - One hundred eighteen women who developed endomyometritis after cesarean section in Parkland Memorial Hospital were treated with parenteral cefotaxime sodium. The requirement for additional antimicrobial therapy was significantly higher at an initial daily dose of 3 g/day (16.4%) than when the dose was 6 g/day (4.8%) (P < .05). The latter clinical efficacy and the observed in vitro susceptibility of 88% of isolates indicate that cefotaxime is well suited for single-agent parenteral therapy for this polymicrobial pelvic infection. Subsequently, 120 women with the same diagnosis were randomly treated with cefotaxime or clindamycin and gentamicin. Patient populations, surgical variables, in vitro microbiologic data, and side effects were similar for both groups. Clinical success observed was also similar: it was 97.5% for women given cefotaxime and 95% for women given clindamycin and gentamicin.

AB - One hundred eighteen women who developed endomyometritis after cesarean section in Parkland Memorial Hospital were treated with parenteral cefotaxime sodium. The requirement for additional antimicrobial therapy was significantly higher at an initial daily dose of 3 g/day (16.4%) than when the dose was 6 g/day (4.8%) (P < .05). The latter clinical efficacy and the observed in vitro susceptibility of 88% of isolates indicate that cefotaxime is well suited for single-agent parenteral therapy for this polymicrobial pelvic infection. Subsequently, 120 women with the same diagnosis were randomly treated with cefotaxime or clindamycin and gentamicin. Patient populations, surgical variables, in vitro microbiologic data, and side effects were similar for both groups. Clinical success observed was also similar: it was 97.5% for women given cefotaxime and 95% for women given clindamycin and gentamicin.

UR - http://www.scopus.com/inward/record.url?scp=0021023247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021023247&partnerID=8YFLogxK

M3 - Article

C2 - 6310464

AN - SCOPUS:0021023247

VL - 62

SP - 489

EP - 497

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 4

ER -